Personal Injury Lawyer -

Free case review

facebook logo google+ logo twitter logo youtube logo

Free Case Review



Opioid Supplier Privileges Revoked

DEA Cleared to Block Opioid Supplier’s Sales

July 17, 2017
The District Court in Washington, D.C., has granted the Drug Enforcement Administration (DEA) the authority to revoke the controlled-substance vending privileges of Masters Pharmaceutical. The ruling comes after Masters had repeatedly failed to enact safeguards that were intended to filter out suspicious orders that had been placed for its prescription opioid painkillers.

Drug sellers are legally obligated to follow up on drug orders that carry a whiff of illicit distribution. Masters, however, has repeatedly failed to do so; the DEA may, therefore, revoke the company’s ability to deal in controlled substances at any market level. The formal measure by which the DEA enacts this penalty is a revocation of the company’s certificate of registration.

The ruling comes after the DEA alleged in 2013 that Masters Pharmaceutical had provided millions of doses of the prescription opioid painkiller oxycodone to eight illicit pharmacies.

Oxycodone is one of several opioid medications that are often named in the so-called “opioid epidemic” that has claimed the lives of more than 30,000 Americans in recent years.

Masters Pharmaceutical has been on the DEA watchlist for some years, after a series of violations of drug-selling protocol brought it to the attention of federal authorities.

If your life, or the life of someone you love, has been jeopardized by prescription opioids, the expert attorneys at can help you.

Talk with aN Attorney now!   

Related Articles

VA urged to address risks of opioids for veterans
More states added to lawsuit against opioid makers
Drugstores try to block cherokee opioid lawsuit
Insys settles Illinois opioid lawsuit
Opioid epidemic
Insys Blue Cross and Blue Shield lawsuit
Fentanyl likely cause of boys death
FDA urged to block opioid suppliers
Painkiller Opana
Opioid Atty Gen
FDA urged to remove opioids from market
FDA urges Opana to be pulled from the shelves
FDA warning
Oxycontin secret marketing
FDA approved drugs
FDA denies use of blue dye in opioids
FDA faults Canadian drugmaker for opioid abuse
Opioid lawsuit settlement
Opioids causing National epidemic
Opioid privileges revoked

Talk with aN Attorney now!’s award winning lawyers have been featured in over 50 radio and television interviews including: tv station logos

Real lawyers, real results!

no recovery, no fee!